Improving executive function in young people with 22q11.2 deletion syndrome using brain stimulation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the effects of transcranial alternating current stimulation (tACS) on cognitive function in children, adolescents, and young adults with 22q11.2 deletion syndrome. The study aims to enhance visual working memory performance through a non-invasive brain stimulation protocol tailored to individual participants. By targeting cognitive deficits early, the research seeks to mitigate the risk of developing psychotic symptoms later in life. Participants will receive at-home tACS treatments using the Starstim-Home device, allowing for personalized intervention based on their specific needs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Confirmed genetic diagnosis of 22q11DS
* Age between 14 and 25 years old
* Willingness to participate
* Informed Consent signed by the subject and/or the caregiver(s)

Exclusion Criteria:

* Epilepsy
* Deep brain stimulation electrodes
* Traumatic brain injury
* Facial metal implants

Where it's running

• University of Geneva
  Geneva, Canton of Geneva, Switzerland Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing Sertraline and Placebo for Treating Anxiety in Children with Neurodevelopmental Disorders

  This study is testing if the medication sertraline can help reduce anxiety in children and teens aged 8-17 with neurodevelopmental disorders like autism and Fragile X syndrome compared to a placebo.

  Recruiting at 6 sites Phase 2 Holland Bloorview Kids Rehabilitation Hospital · Calgary, Alberta and 6 other locations · NCT06081348

• Observing the health management of patients with rare genetic syndromes

  This study looks at how patients with rare genetic syndromes like Prader-Willi and Klinefelter manage their health as they move from children's care to adult care to see what support they need.

  Recruiting Erasmus Medical Center · Rotterdam, South Holland · NCT04463316

• Long-Term Recovery and Quality of Life after Sepsis in ICUs

  This international study follows adults with sepsis in ICUs to see how their quality of life and other outcomes look six months later.

  Recruiting University of Geneva, Switzerland · Geneva · NCT07863128

• Ceftazidime (±avibactam) with IV fosfomycin versus ceftazidime alone for hospitalized adults with severe suspected Gram‑negative infection

  This trial will test whether adding intravenous fosfomycin to ceftazidime (or ceftazidime‑avibactam) helps hospitalized adults with suspected severe Gram‑negative infections recover faster than ceftazidime alone.

  Recruiting Phase 3 University of Geneva, Switzerland · Geneva, Canton of Geneva · NCT07063095

• Comparing two therapies for insomnia treatment

  This study is testing whether a new sleep therapy called Bedtime Restriction Therapy works just as well as the more common Cognitive Behavioral Therapy for Insomnia to help adults with insomnia sleep better.

  Recruiting at 2 sites University of Geneva, Switzerland · Bern, Canton of Bern and 1 other locations · NCT06767137

• Using a single implant to stabilize lower dentures in older adults

  This study is testing if putting one implant in the side of the jaw can help older adults with complete dentures feel more stable and comfortable compared to the usual method of placing the implant in the center.

  Recruiting University of Geneva, Switzerland · Geneva, Canton of Geneva · NCT06755034

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.